The Springer Nature medical journal Cureus, sibling to Nature and Scientific American, published a peer-reviewed paper by high-profile mRNA vaccine critics last month, showing the growing mainstream openness to data and arguments once nitpicked if not ignored by publishers and suppressed by academia and Big Tech.
The feds have struggled to keep interest high in each new formulation of the COVID vaccines, with fewer than 12% of minors, 22% of adults and just 41% of those 65 and up taking the 2023-2024 vaccines, according to the latest weekly National Immunization Survey.
While early reports from the mRNA trials said the novel vaccines "Could greatly reduce COVID-19 symptoms," re-analysis of Pfizer's trial data "Identified statistically significant increases" in serious adverse events in the intervention group, which then became unmistakable after emergency use authorization, the Cureus paper says.
Sen. Ron Johnson, R-Wis., told the Times the refusal to send the alert was "Not only inexcusable, it's malpractice." The ranking Republican on the Senate Homeland Security and Governmental Affairs Committee's investigations subcommittee has long pressed the feds to release their COVID vaccine safety data.
The only commonality among patients is a recent COVID booster, Dalgleish said, warning of a "Covid booster cancer time bomb." He theorized vaccines could imperil cancer patients because of reports that "T cell responses are suppressed after the boosters" as well as the so-called IgG4 class switch observed to follow repeat jabs, when the body shifts to noninflammatory antibodies that moderate rather than neutralize infections.
While claiming without evidence that COVID vaccines are "Effective prophylactic measures for reducing virus transmission rates," the Louisiana State University researchers found that "Spike-specific IgG4 levels" in uninfected Pfizer recipients were "Markedly elevated" after the booster but not the two-dose series.
The 16 healthy participants were monitored over 420 days for evidence of natural infection - antibody responses to the nucleocapsid protein - to ensure the measured response came from the jabs alone, the authors wrote in the journal Vaccines, published by Swiss open-access publisher MDPI. "Although strong neutralization responses were detected in two- and three-dose vaccine sera [blood], these rapidly decayed to pre-immune levels by four and six months, respectively," they said.
No comments:
Post a Comment